Chew Shun Chang

Title: Chew Shun Chang: Innovator in Antibody Development

Introduction

Chew Shun Chang is a notable inventor based in Quincy, MA (US), recognized for his contributions to the field of antibody development. With a total of 4 patents, he has made significant strides in the treatment of cancer through innovative therapeutic approaches.

Latest Patents

One of his latest patents is titled "Antibodies specific for GUCY2c and uses thereof." This invention provides novel antibodies that specifically bind to GUCY2c, offering potential applications in cancer treatment. Additionally, it includes bispecific antibodies that utilize these antibodies for therapeutic purposes. Another important patent is "CD1a antibodies and uses thereof," which presents antibodies and antigen-binding fragments that specifically target Cluster of Differentiation 1a (CD1a). This patent outlines various uses and methods associated with these antibodies.

Career Highlights

Throughout his career, Chew Shun Chang has worked with prominent organizations such as Pfizer Corporation and Children's Medical Center Corporation. His experience in these institutions has contributed to his expertise in the field of biomedical research and innovation.

Collaborations

Chew has collaborated with notable professionals in his field, including Gurkan Guntas and Madan Katragadda. These partnerships have further enhanced his research and development efforts.

Conclusion

Chew Shun Chang's work in antibody development showcases his commitment to advancing cancer treatment through innovative inventions. His contributions are significant in the ongoing fight against cancer, and his patents reflect his dedication to improving healthcare outcomes.